Literature DB >> 3933981

[Causal analytic studies on demonstration of neuroendocrine parameters in combined hypoglycemia test in depressive subgroups].

A Czernik, E M Steinmeyer.   

Abstract

With the help of an analytical path structure model (causal analysis) the aim of the study was to elucidate further, in female patients with various depressive disorders, some correlations of causal interdependencies between changes both in basal secretion of anterior pituitary hormones and in their responses to the (combined) insulin tolerance test (ITT) with extraneous factors--such as age, deviation from ideal body weight (in percentage), severity of depression and score in the Newcastle Scale (NCS)--that may influence these abnormalities. In various depressive subgroups the strength of influence and the different importance of deviation from ideal body weight and basal growth hormone (GH) concentration (as exclusion criteria) for their neuroendocrine reactivity in the combined ITT was shown. The hypothesis that cortisol hypersecretion may be the primary disturbance and the other possible neuroendocrine changes such as blunted GH, cortisol and TSH responses to stimuli in some depressive patients all may be secondary to the (elevated) cortisol level could not be corroborated. The endogenous mono- and bipolar subtypes of major depressive disorders showed intimate connections between the various neuroendocrine functional systems and the above mentioned extraneous factors resulting in a narrowed variability and a stronger coupling in the reactivity of these hormonal functional systems, a condition which can be seen as analogous to experimental results at the psychophysiological level in these nuclear groups of depressed patients, whose psychopathological state is also characterized by similar limitations in their "degree of freedom" (Heimann).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3933981     DOI: 10.1007/bf00633482

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  25 in total

1.  Neuroendocrine and amine studies in affective illness.

Authors:  R C Casper; J M Davis; G N Pandey; D L Garver; H Dekirmenjian
Journal:  Psychoneuroendocrinology       Date:  1977       Impact factor: 4.905

2.  Influence of cortisol on TRH-induced TSH response in depression.

Authors:  P T Loosen; A J Prange; I C Wilson
Journal:  Am J Psychiatry       Date:  1978-02       Impact factor: 18.112

3.  Studies of the sex based variation of human growth hormone secretion.

Authors:  T J Merimee; S E Fineberg
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

4.  Effects of estrogen and sex difference on secretion of human growth hormone.

Authors:  A G Frantz; M T Rabkin
Journal:  J Clin Endocrinol Metab       Date:  1965-11       Impact factor: 5.958

5.  Glucocorticoid suppression of pancreatic and pituitary hormones: pancreatic polypeptide, growth hormone, and prolactin.

Authors:  R A Lantigua; W F Streck; D H Lockwood; L S Jacobs
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

6.  Insulin tolerance test: human growth hormone response and insulin resistance in primary unipolar depressed, bipolar depressed and control subjects.

Authors:  S H Koslow; P E Stokes; J Mendels; A Ramsey; R Casper
Journal:  Psychol Med       Date:  1982-02       Impact factor: 7.723

7.  Hypothalamic--pituitary function in depressive illness: insensitivity to hylycaemia.

Authors:  B J Carroll
Journal:  Br Med J       Date:  1969-07-05

8.  Relationship of thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression.

Authors:  I Extein; A L Pottash; M S Gold
Journal:  Psychiatry Res       Date:  1981-02       Impact factor: 3.222

9.  Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?

Authors:  M Berger; P Doerr; R Lund; T Bronisch; D von Zerssen
Journal:  Biol Psychiatry       Date:  1982-11       Impact factor: 13.382

10.  Thyrotropin releasing hormone (TRH): a useful tool for psychoneuroendocrine investigation.

Authors:  P T Loosen; A J Prange
Journal:  Psychoneuroendocrinology       Date:  1980-01       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.